Acta physiologica (Oxford, England) · 2026
Angiotensin-(1-7) Alleviates Isoproterenol-Induced Cardiac Hypertrophy by Suppressing Autophagy and Apoptosis Through the Synergistic Action of Mas Receptor and Angiotensin II Type 2 Receptor.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Xiaomei, Guo Fei, Wang Xiaoqian, Guo Yu, Fan Siyao, Hong Lan, Jin Honghua
Аннотация
AIM: The aim of this study is to determine whether Angiotensin-(1-7) [Ang-(1-7)] alleviates isoproterenol (ISO)-induced cardiac hypertrophy by suppressing excessive autophagy and apoptosis through coordinated Mas receptor (MasR) and angiotensin II type-2 receptor (AT2R) signaling, and to elucidate the underlying mechanisms.
METHODS: ISO-induced hypertrophy was established in mice and assessed by echocardiography, histology, and hypertrophic markers. H9c2 cardiomyocytes were exposed to ISO and treated separately with A-779 (MasR antagonist), PD123319 (AT2R antagonist), and a combination of both receptor antagonists. Receptor interplay was examined using pharmacological blockade and co-immunoprecipitation. Autophagy and apoptosis were evaluated by transmission electron microscopy and TUNEL.
RESULTS: Ang-(1-7) attenuated ventricular dysfunction, myocardial enlargement, and upregulation of hypertrophic markers in mice with ISO-induced hypertrophy. Pharmacological inhibition with A-779 and PD123319 revealed that Ang-(1-7) actions require reciprocal regulation between MasR and AT2R. Both receptors synergistically contributed to the anti-apoptotic effect, while the anti-autophagic response was mediated predominantly by MasR. Transmission electron microscopy and TUNEL staining confirmed that Ang-(1-7) treatment alleviated excessive autophagy and apoptosis in cardiomyocytes. Furthermore, experiments with dual receptor antagonists and co-immunoprecipitation showed an interaction between MasR and AT2R, supporting their coordinated signaling role in cardiac protection.
CONCLUSION: Ang-(1-7) ameliorates ISO-induced cardiac hypertrophy by suppressing excessive autophagy and apoptosis via synergistic MasR-AT2R signaling. Receptor crosstalk may represent a therapeutic entry point for pathological hypertrophy.
METHODS: ISO-induced hypertrophy was established in mice and assessed by echocardiography, histology, and hypertrophic markers. H9c2 cardiomyocytes were exposed to ISO and treated separately with A-779 (MasR antagonist), PD123319 (AT2R antagonist), and a combination of both receptor antagonists. Receptor interplay was examined using pharmacological blockade and co-immunoprecipitation. Autophagy and apoptosis were evaluated by transmission electron microscopy and TUNEL.
RESULTS: Ang-(1-7) attenuated ventricular dysfunction, myocardial enlargement, and upregulation of hypertrophic markers in mice with ISO-induced hypertrophy. Pharmacological inhibition with A-779 and PD123319 revealed that Ang-(1-7) actions require reciprocal regulation between MasR and AT2R. Both receptors synergistically contributed to the anti-apoptotic effect, while the anti-autophagic response was mediated predominantly by MasR. Transmission electron microscopy and TUNEL staining confirmed that Ang-(1-7) treatment alleviated excessive autophagy and apoptosis in cardiomyocytes. Furthermore, experiments with dual receptor antagonists and co-immunoprecipitation showed an interaction between MasR and AT2R, supporting their coordinated signaling role in cardiac protection.
CONCLUSION: Ang-(1-7) ameliorates ISO-induced cardiac hypertrophy by suppressing excessive autophagy and apoptosis via synergistic MasR-AT2R signaling. Receptor crosstalk may represent a therapeutic entry point for pathological hypertrophy.